Relationship between duration of treatment and urine protein in pulmonary tuberculosis patients

Authors

  • Randy Sadid Department of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pontianak, Pontianak, West Kalimantan, Indonesia
  • Maulidiyah Salim Department of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pontianak, Pontianak, West Kalimantan, Indonesia
  • Ari Nuswantoro Department of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pontianak, Pontianak, West Kalimantan, Indonesia
  • Mohd Yunus Faculty of Medicine, Jalalabad State University, Jalal-Abad, Kyrgyzstan

DOI:

https://doi.org/10.53770/electron.v7i1.521

Keywords:

Tuberculosis, Urine protein, Length of Treatment

Abstract

Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. TB treatment is an efficient way to prevent the spread of the bacteria. The goals of TB treatment include curing, maintaining the patient's quality of life and productivity, preventing death from active TB or its sequelae, preventing relapse, reducing transmission to others, and preventing drug resistance. Most TB patients complete treatment without significant side effects, but a minority experience significant side effects. The duration of drug consumption can affect other organs such as the kidneys. Proteinuria is a condition in which there is protein in the urine beyond normal limits. The purpose of this study was to determine the relationship of length of treatment to urine protein in TB patients in Meliau District. This research method is analytical observational with a cross-sectional approach and consecutive sampling technique, with a total sample of 47 respondents. The results showed 10 respondents (21.27%) experienced proteinuria, while 37 respondents (78.73%) did not. Chi-Square analysis showed a relationship between length of treatment and urine protein in TB patients in Meliau District, as evidenced by a p-value of 0.015 (<0.05). In conclusion, there is a relationship between length of treatment and urine protein in TB patients in Meliau District.

References

Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., ... & Zumla, A. (2021). Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts. International journal of infectious diseases, 113, S7-S12.https://doi.org/10.1016/j.ijid.2021.02.107

Choirunnisa, H., S. Ujiani, and H. Y. Kusuma. (2022). The Relationship between Stages of Taking OAT and Urine Protein of Pulmonary Tuberculosis Patients at the Panjang and Sukaraja Health Centers in Bandar Lampung City. Diploma thesis, Poltekkes Tanjungkarang.

Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., ... & Warren, R. M. (2017). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The lancet Respiratory medicine, 5(4), 291-360.

Djasang, S., & Saturiski, M. (2019). Study on the Results of Urea and Uric Acid Examination in Patients With Pulmonary Tuberculosis Taking Intensive Anti-Tuberculosis (OAT) Drugs. Journal of Health Analyst Media, 10(1), 1–7. https://doi.org/10.32382/mak.v10i1.985

Kaona, F. A., Tuba, M., Siziya, S., & Sikaona, L. (2004). An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public health, 4(1), 68.https://doi.org/10.1186/1471-2458-4-68

Kompala, T., Shenoi, S. V., & Friedland, G. (2013). Transmission of tuberculosis in resource-limited settings. Current Hiv/aids Reports, 10(3), 264-272.https://doi.org/10.1007/s11904-013-0164-x

Sankineni, S., Chauhan, S., Shegokar, R., & Pathak, Y. (2023). Global health and tuberculosis; past, present, and future. In Tubercular Drug Delivery Systems: Advances in Treatment of Infectious Diseases (pp. 1-13). Cham: Springer International Publishing.

Sanggau Health Office. (2023). TB Outcome Report. Sanggau: Sanggau Health Office.

Tangkin, C. P., Mongan, A. E., & Wowor, M. F. (2016). Gambaran protein urin pada pasien tuberkulosis paru dewasa di RSUP Prof. Dr. RD Kandou Manado. eBiomedik, 4(2).

Ministry of Health. (2020). Management of Drug Resistant Tuberculosis in Indonesia. Jakarta: Indonesian Ministry of Health.

Notoadmojo, S. (2018). Health Research Methods. Jakarta: Rineka Cipta.

Nursidika, P., Furqon, A., Hanifah, F., & Anggraini, D. R. (2017).Gambaran Abnormalitas Organ Hati Dan Ginjal Pasien. Kartika Health Journal, 12(1).

Sugiyono. (2013). Quantitative Qualitative Research Methods R&D. Bandung: Alfabeta.

Sunarmi, S., & Kurniawaty, K. (2022). Hubungan Karakteristik Pasien Tb Paru Dengan Kejadian Tuberkulosis. Jurnal ’Aisyiyah Medika, 7(2), 182–187.

World Health Organization. (2010). Treatment of tuberculosis: guidelines. World Health Organization.

Downloads

Published

2025-01-31

How to Cite

Sadid, R., Salim, M., Nuswantoro, A., & Yunus, M. (2025). Relationship between duration of treatment and urine protein in pulmonary tuberculosis patients . ELECTRON (Journal of Science and Technology), 7(1), 37–43. https://doi.org/10.53770/electron.v7i1.521

Issue

Vol. 7 No. 1 (2025): ELECTRON (Journal of Science and Technology)

Section

Articles

License

Copyright (c) 2025 ELECTRON (Journal of Science and Technology)

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.